Pharmaceutical Logistics Market Size, Share, Regional Growth, 2026-2034

Market OverviewAccording to fortune business insights, The global pharmaceutical logistics market size was valued at USD 80.56 billion in 2025. The market is projected to grow from USD 85.15 billion in 2026 to USD 156.39 billion by 2034, exhibiting a CAGR of 7.90% during the forecast period. Europe dominated the pharmaceutical logistics market with a market share of 65.34% in 2025.The analysis shows that top companies are investing more in advanced logistics because of the increasing demand for temperature-sensitive products. For example, SkyCell partnered with Microsoft in April 2025 to integrate its AI-powered supply chain solution, enhancing real-time visibility for pharmaceutical shipments. This trend indicates a strong demand for specialized pharmaceutical logistics worldwide.

Major Players Profiled in the Market Report:

• DHL (Bonn, Germany)

• Kuehne + Nagel (Schindellegi, Switzerland)

• UPS Healthcare (Georgia, U.S.)

• FedEx Supply Chain (Tennessee, U.S.)

• CEVA Logistics (Marseille, France)

• C.H. Robinson (Minnesota, U.S.)

• DB Schenker (Essen, Germany)

• DSV (Hedehusene, Denmark)

• XPO Logistics (Connecticut, U.S.)

• GEODIS (Levallois-Perret, France)

SegmentsFlexibility and Last-Mile Solutions Propel Roadways Segment GrowthBased on transportation mode, the market is divided into airways, railways, roadways, and waterways. The roadways segment holds the largest market share and dominates the market owing to its flexibility, cost-effectiveness, and crucial role in providing last-mile delivery to pharmacies, hospitals, and clinics.

Need for Secure and Reliable Delivery to Drive Transportation Segment ExpansionBy service type, the market is categorized into warehouse services, transportation, inventory management, and administration & supplies. The transportation segment is leading the market as there is a high demand for fast, secure, and reliable delivery of medicines globally, requiring careful planning to comply with regulations and ensure product integrity.

Vast Volume of Products Augments Non-cold Chain Segment GrowthBased on logistics type, the market is segmented into cold chain and non-cold chain. The non-cold chain segment holds the largest market share owing to the vast volume of non-temperature-sensitive products, such as many finished pharmaceuticals and over-the-counter medicines, that require strong global distribution networks.

Consistent Global Distribution Propels Finished Pharmaceutical Goods Segment GrowthBased on product type, the market is split into finished pharmaceutical goods, biopharmaceuticals, and others. The finished pharmaceutical goods segment leads market growth owing to the consistent need for distribution of items like tablets, capsules, and syrups to global healthcare markets, driven by rising healthcare access and chronic disease prevalence.

Drivers & RestraintsRising Demand for Biologics and Specialty Drugs to Propel Market GrowthThe rapid growth in biologics and specialty drugs has raised the demand for advanced logistics, as these products are highly sensitive to temperature and handling, requiring specialized cold chain infrastructure and real-time monitoring to maintain product integrity, boosting pharmaceutical logistics market growth.However, the complex and fragmented regulatory landscape across different countries, which increases operational costs and compliance challenges, may hamper market growth.

Source: https://www.fortunebusinessinsights.com/pharmaceutical-logistics-market-109622

Regional InsightsEstablished Healthcare System in Europe Propels Regional Market GrowthEurope holds the dominant pharmaceutical logistics market share and is projected to experience steady growth. The region’s growth is attributed to its well-established healthcare system, a strong regulatory framework ensuring Good Distribution Practices (GDP), and high demand for advanced biologics and specialty drugs.Asia Pacific is one of the fastest-growing regions in the market. The growth is attributed to increasing demand for affordable healthcare, rising healthcare investments, and the region's expanding role as a pharmaceutical manufacturing hub.

Pharmaceutical Logistics Market Future Growth:The pharmaceutical logistics market is experiencing robust growth, fueled by rising demand for biologics and other temperature-sensitive drugs, the expansion of e-commerce and Direct-to-Patient (DTP) delivery models, and the increasing outsourcing of logistics to 3PLs. Today's supply chains are increasingly reliant on advanced technologies like IoT, AI, and blockchain to enhance real-time visibility, ensure regulatory compliance, and maintain product integrity through sophisticated cold chain management. While Europe continues to dominate due to its mature infrastructure, the Asia-Pacific region is seeing a surge in demand, driven by growing manufacturing capabilities and rising healthcare access.

Competitive LandscapeGrowing Adoption of Mergers and Acquisitions Strategies to Propel Market GrowthThe market features prominent players like DHL, Kuehne + Nagel, and UPS Healthcare. These leading companies are accelerating growth through strategic initiatives such as mergers and acquisitions, partnerships, and investment in advanced technologies like AI and IoT to enhance their cold chain capabilities and expand their global networks. Their proactive approach to adapting to the complex demands of the pharmaceutical industry continues to fuel the market’s momentum.

Key Industry Developments

• March 2025: Identiv partnered with Tag-N-Trac to launch a real-time cold chain tracking solution, enabling continuous monitoring of temperature and humidity during transit for pharmaceutical products.

• January 2025: Pharma Logistics, LLC and Rx Reverse Distributors, Inc. announced their merger, creating the largest pharmaceutical reverse distribution provider for retail pharmacies.